Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC25A5 | P05141 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20630505 | 0.78 | ALDH1A1 (0.31) | — | |
| SCHEMBL20629962 | 0.73 | SLC25A5 (0.32) | SLC25A5 | |
| SCHEMBL20629961 | 0.72 | — | — | |
| SCHEMBL207239 | 0.63 | — | — | |
| SCHEMBL140703 | 0.63 | — | — | |
| SCHEMBL11366039 | 0.62 | SLC25A5 (0.30) | SLC25A5 | |
| SCHEMBL13109063 | 0.62 | SLC25A5 (0.30) | SLC25A5 | |
| SCHEMBL13296224 | 0.62 | TSHR (0.42) | — | |
| SCHEMBL1829178 | 0.62 | — | — | |
| SCHEMBL16405148 | 0.62 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240065265-A1 | METHODS FOR CONTROL OF PESTS | BIO-GENE TECHNOLOGY LIMITED (AU) | 2024-02-29 | — | — | US | disclosed |
| US-20240065265-A1 | METHODS FOR CONTROL OF PESTS | BIO-GENE TECHNOLOGY LIMITED (AU) | 2024-02-29 | — | — | US | disclosed |
| US-11800866-B2 | Methods for control of pests | Bio-Gene Technology Unlimited (AU) | 2023-10-31 | — | — | US | disclosed |
| US-11800866-B2 | Methods for control of pests | Bio-Gene Technology Unlimited (AU) | 2023-10-31 | — | — | US | disclosed |
| US-20230292751-A1 | CONTROL OF RESISTANT PESTS | BIO-GENE TECHNOLOGY LIMITED (AU) | 2023-09-21 | — | — | US | disclosed |
| US-20230292751-A1 | CONTROL OF RESISTANT PESTS | BIO-GENE TECHNOLOGY LIMITED (AU) | 2023-09-21 | — | — | US | disclosed |
| US-11712039-B2 | Control of resistant pests | BIO-GENE TECHNOLOGY LIMITED (AU) | 2023-08-01 | — | — | US | disclosed |
| US-11712039-B2 | Control of resistant pests | BIO-GENE TECHNOLOGY LIMITED (AU) | 2023-08-01 | — | — | US | disclosed |
| US-20210051951-A1 | CONTROL OF RESISTANT PESTS | BIO-GENE TECHNOLOGY LIMITED (AU) | 2021-02-25 | — | — | US | disclosed |
| US-20200323202-A1 | CONTROL OF RESISTANT PESTS | BIO-GENE TECHNOLOGY LIMITED (AU) | 2020-10-15 | — | — | US | disclosed |
| WO-2019191812-A1 | METHODS FOR CONTROL OF PESTS | BIO-GENE TECHNOLOGY LIMITED (AU) | 2019-10-10 | — | — | WO | disclosed |
| WO-2019006516-A1 | CONTROL OF RESISTANT PESTS | BIO-GENE TECHNOLOGY LIMITED (AU) | 2019-01-10 | — | — | WO | disclosed |
| WO-2019006514-A1 | PEST MANAGEMENT | BIO-GENE TECHNOLOGY LIMITED (AU) | 2019-01-10 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200323202-A1 | CONTROL OF RESISTANT PESTS | DDT, TKT, L3MBTL4 | SLC25A5 2905/4885 |
| US-20210051951-A1 | CONTROL OF RESISTANT PESTS | TKT, KHK, PKM | SLC25A5 2376/4885 |
| US-20240065265-A1 | METHODS FOR CONTROL OF PESTS | ACHE, DDT, CTRL | SLC25A5 4155/4885 |
| US-11800866-B2 | Methods for control of pests | VRK1, TREH, AKR7A2 | SLC25A5 3017/4885 |
| US-11712039-B2 | Control of resistant pests | TKT, KHK, PKM | SLC25A5 2376/4885 |
| US-20230292751-A1 | CONTROL OF RESISTANT PESTS | TKT, KHK, PKM | SLC25A5 2376/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.